Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 21, 1997 - Issue 4
26
Views
4
CrossRef citations to date
0
Altmetric
Original Article

A New Fast-Moving Variant Causing Erythrocytosis and Mild Hemolysis: HB Gàmbara [β82(EF6)Lys→glu]

, , , , , , , , , & show all
Pages 345-361 | Received 01 Sep 1996, Accepted 21 Apr 1997, Published online: 07 Jul 2009
 

Abstract

Hb Gámbara is a new hemoglobin variant with abnormal β chains that has been found in three out of four members of a family of Lombardy origin (Gàmbara, Brescia, Northern Italy). The affected subjects led a normal life, but they had modest erythrocytosis and mild (compensated) hemolysis with slight splenomegaly. Their abnormal hemoglobin was about 52% of the total hemoglobin, and was shown to be stable by the isopropanol test. Whole blood P50 of the proband was 19.3 Torr, Bohr effect was decreased (-0.25), as well as the molar ratio between the 2,3diphosphoglycerate level and total hemoglobin of erythrocytes (0.68). The purified abnormal hemoglobin was characterized by an altered oxygen affinity, low n-factor, chloride, and 2,3-diphosphoglycerate effects. The Bohr effect was about 40% of the normal control. The abnormal hemoglobin moved faster than Hb A at alkaline electrophoresis, and split into two fractions, probably due to the formation of hybrid tetramers (α2βAβX). The reversed phase high performance liquid chromatogram from the tryptic digest of the aminoethylated abnormal β chain subunits indicated the presence of an extra peptide, βT-9,10, replacing the individual peptides βT-9 and βT-10. Finally, the proband's DNA, drawn from a suitable segment of the β structural gene (exon 2), revealed a nucleotide sequence carrying the heterozygous mutation AAG→GAG at codon 82. This led to a Lys→Glu substitution at position 82(EF6) of the β chain.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.